A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) and chronic hepatitis B (CHB) are both the most common underlying diseases leading to cirrhosis and hepatocellular carcinoma, and NAFLD and HBV infection are the first and second leading causes of chronic liver disease in China. However, there are...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yandong, Liu, Qiang, Han, Jing, Gao, Siyu, Xiao, Qian, Huang, Xiaoli, Lu, Lu, Zhou, xiaolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550465/
https://www.ncbi.nlm.nih.gov/pubmed/36225715
http://dx.doi.org/10.1155/2022/4774195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550465/
https://www.ncbi.nlm.nih.gov/pubmed/36225715
http://dx.doi.org/10.1155/2022/4774195

Ejemplares similares